Publication: 4276

Publication: 4276

Randomized Phase II/III Study of R-CHOP +/- Venetoclax in Previously Untreated MYC/BCL2 Double Expressor Diffuse Large B Cell Lymphoma (DLBCL): Alliance A051701

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 24 (16_suppl) 7012

Meeting Instance:: ASCO 2024
Year:: 2024
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG

Corr. Author:
Authors:: Jeremy S. Abramson Susan Geyer Levi Pederson Sharmila Giri Eric D. Hsi Richard F. Little Steven Gore Daniel Landsburg Hua-Jay Cherng Brad Kahl Neha Mehta-Shah Shira Dinner Jonathan W. Friedberg Nancy L. Bartlett John P. Leonard

Networks:: LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-MO011, MD001, NY018, PA121

Study: Alliance-A051701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: